OEM News

First Case with HAPPE Spine’s INTEGRATE-C Interbody Cage

The interbody fusion cage is fully integrated with porosity and hydroxyapatite for a better healing environment.

HAPPE Spine has completed the first clinical case using its INTEGRATE-C interbody fusion system. It was performed by co-inventor and neurosurgeon Dr. Stephen Smith, MD, at the Beacon Health System – Memorial Hospital in South Bend, Ind.
 
According to the company, INTEGRATE-C is the first interbody fusion cage that’s fully integrated with porosity and hydroxyapatite (HA) for a better healing environment. The interconnected, cancellous porosity of the implant promotes bone ingrowth from endplate to endplate, and HA is exposed on all implant surfaces to promote cell signaling and bone on-growth.
 
INTEGRATE-C is radiovisible and radiolucent to improve intra-op imaging and post-op fusion assessment.
 
Dr. Smith told the press, “The INTEGRATE-C handled extremely well and went right to work. The porosity immediately draws blood and any autologous factors into the implant to promote healing. Radiographic visibility was excellent, and once implanted the INTEGRATE-C even looks like bone.”
 
Dr. Ryan K. Roeder, Ph.D., founder of HAPPE Spine and co-inventor of the HAPPE material platform and INTEGRATE-C said, “This is a momentous milestone in a journey that began with an idea to INTEGRATE porosity and hydroxyapatite into polyetheretherketone at a time when PEEK interbody fusion cages were still new. Many team members have worked diligently to develop a product that has the potential to improve patient outcomes.”
 
Andrew Iott, CEO of HAPPE Spine added, “We are now excited to kick-off a strategic limited user release aimed at establishing clinical data supporting the efficacy of the innovative HAPPE biomaterial platform and the INTEGRATE product line. A national launch will commence later this year.”

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters